Olanzapine trials Keck, et al. World J Psychiatry 2004;5(Suppl 1);50 [Abstract] Also: Keck P, et al. Eur Neuropsychopharmacol 2003;13(Suppl 4):S212. Ketter, et al. World J Psychiatry 2004;5(Suppl 1):51 [Abstract]. Sanger TM, et al. J Clin Psychiatry 2001;62:273–81.  Shi L, et al. Clin Ther 2004;26:125–34. Tohen, et al. World J Psychiatry 2004;5(Suppl 1):51 [ Abstract]. Tohen, et al. World J Psychiatry 2004;5(Suppl 1):51 [Abstract]. Tohen et al. Arch Gen Psychiatry 2004;60:1079–88. Also: World J Psychiatry 2004;5(Suppl 1):50 [Abstract]. Tohen M, et al. Am J Psychiatry 2003;160:1263–71. Guidelines: WFSBP: Grunze, et al. World J Biol Psychiatry 2003; 4:5-13. Danish Guidelines: Licht, et al. Acta Psychiatry Scand 2003;108(S419):1-22.  Australian Guidelines: Mitchell PB, et al. Australasian Psychiatry 11(1):39-53. BAP Guidelines: Goodwin, et al. J Psychopharmacol 2003;17:149-73. APA Guidelines: Hirschfeld, et al. Am J Psychiatry 2002;159(4 Suppl):1-50. ICG Guidelines: J Clin Psychiatry 2004;65:(In press).